{{Rsnum
|rsid=4485648
|Gene=TXNRD2
|Chromosome=22
|position=19931882
|Orientation=plus
|GMAF=0.242
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TXNRD2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 33.8 | 66.2
| HCB | 0.0 | 15.6 | 84.4
| JPT | 0.0 | 22.7 | 77.3
| YRI | 22.2 | 50.8 | 27.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 15.6 | 84.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21716162
|Title=Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer
|OA=1
}}{{PMID|18574484|OA=1
}} The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase.

{{PMID|19015200|OA=1
}} Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer.